BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 2142858)

  • 1. Atrial natriuretic peptide augments forearm capillary filtration in humans.
    Groban L; Cowley AW; Ebert TJ
    Am J Physiol; 1990 Jul; 259(1 Pt 2):H258-63. PubMed ID: 2142858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial natriuretic peptide increases human capillary filtration and venous distensibility.
    Ando S; Imaizumi T; Harada S; Hirooka Y; Takeshita A
    J Hypertens; 1992 May; 10(5):451-7. PubMed ID: 1317906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arterial and venous effects of atrial natriuretic peptide in the human forearm.
    Doorenbos CJ; Blauw GJ; van Brummelen P
    Am J Hypertens; 1991 Apr; 4(4 Pt 1):333-40. PubMed ID: 1829369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic atrial natriuretic peptide reduces human leg capillary filtration.
    Watenpaugh DE; Vissing SF; Lane LD; Buckey JC; Firth BG; Erdman W; Hargens AR; Blomqvist CG
    J Cardiovasc Pharmacol; 1995 Sep; 26(3):414-9. PubMed ID: 8583783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ANP-mediated volume depletion attenuates renal responses in humans.
    Ebert TJ; Groban L; Muzi M; Hanson M; Cowley AW
    Am J Physiol; 1992 Dec; 263(6 Pt 2):R1303-8. PubMed ID: 1481943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial natriuretic peptide regulates regional vascular volume and venous tone in humans.
    Schmitt M; Broadley AJ; Nightingale AK; Payne N; Gunaruwan P; Taylor J; Lee L; Cockcroft J; Struthers AD; Frenneaux MP
    Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1833-8. PubMed ID: 12842844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuated forearm vasodilative response to intra-arterial atrial natriuretic peptide in patients with heart failure.
    Hirooka Y; Takeshita A; Imaizumi T; Suzuki S; Yoshida M; Ando S; Nakamura M
    Circulation; 1990 Jul; 82(1):147-53. PubMed ID: 2163779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial natriuretic peptide alters neither capillary filtration nor vascular compliance of both skin and skeletal muscle of humans.
    Rölleke T; Berke B; Arndt JO
    Basic Res Cardiol; 1994; 89(2):192-205. PubMed ID: 8074642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen and progesterone effects on transcapillary fluid dynamics.
    Stachenfeld NS; Keefe DL; Palter SF
    Am J Physiol Regul Integr Comp Physiol; 2001 Oct; 281(4):R1319-29. PubMed ID: 11557642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiologic levels of atrial natriuretic factor do not alter reflex sympathetic control: direct evidence from microneurographic studies in humans.
    Roach PJ; Sanders JS; Berg WJ; Mark AL; Ebert TJ; Ferguson DW
    J Am Coll Cardiol; 1990 May; 15(6):1318-30. PubMed ID: 2139443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial antipressor natriuretic peptide: release mechanisms and vascular action in man.
    Müller FB; Erne P; Raine AE; Bolli P; Linder L; Resink TJ; Cottier C; Bühler FR
    J Hypertens Suppl; 1986 Jun; 4(2):S109-14. PubMed ID: 2941531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasodilating actions of calcitonin gene-related peptide in normal man: comparison with atrial natriuretic peptide.
    Ando K; Ito Y; Ogata E; Fujita T
    Am Heart J; 1992 Jan; 123(1):111-6. PubMed ID: 1530893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of brain natriuretic peptide on forearm vasculature: comparison with atrial natriuretic peptide.
    van der Zander K; Houben AJ; Kroon AA; de Leeuw PW
    Cardiovasc Res; 1999 Dec; 44(3):595-600. PubMed ID: 10690292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of opioid-induced atrial natriuretic peptide release in conscious rats.
    Pesonen A; Leppäluoto J; Ruskoaho H
    J Pharmacol Exp Ther; 1990 Aug; 254(2):690-5. PubMed ID: 2143537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic effects of human atrial natriuretic peptide after modified Fontan procedure.
    Hiramatsu T; Imai Y; Takanashi Y; Seo K; Terada M; Nakazawa M
    Ann Thorac Surg; 1998 Mar; 65(3):761-4. PubMed ID: 9527208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basal and volume expansion-stimulated plasma atrial natriuretic peptide concentrations and hemodynamics in conscious rats: effects of SCH 39.370, an endopeptidase inhibitor, and C-ANF-(4-23), a clearance receptor ligand.
    Kukkonen P; Vuolteenaho O; Ruskoaho H
    Endocrinology; 1992 Feb; 130(2):755-65. PubMed ID: 1531129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of local angiotensin converting enzyme inhibition on the action of atrial natriuretic peptide in the human forearm.
    Cockcroft JR; Allen MJ; Benjamin N; Webb DJ
    J Hum Hypertens; 1989 Feb; 3(1):49-52. PubMed ID: 2542549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of atrial natriuretic peptide in systemic responses to acute isotonic volume expansion.
    Watenpaugh DE; Yancy CW; Buckey JC; Lane LD; Hargens AR; Blomqvist CG
    J Appl Physiol (1985); 1992 Oct; 73(4):1218-26. PubMed ID: 1447062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Forearm vasodilator mechanisms during mental stress: possible roles for epinephrine and ANP.
    Lindqvist M; Kahan T; Melcher A; Bie P; Hjemdahl P
    Am J Physiol; 1996 Mar; 270(3 Pt 1):E393-9. PubMed ID: 8638683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac output during exercise is related to plasma atrial natriuretic peptide but not to central venous pressure in humans.
    Yoshiga C; Dawson EA; Volianitis S; Warberg J; Secher NH
    Exp Physiol; 2019 Mar; 104(3):379-384. PubMed ID: 30673144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.